Febuxostat
NDC 27808-207, febuxostat, tablet, from Tris Pharma Inc.
- Product NDC
- 27808-207
- Status
- Listed
- Labeler
- Tris Pharma Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210292
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27808-207 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEBUXOSTAT80 mg/1
Pharmacologic classes
Xanthine Oxidase Inhibitor [EPC]; Xanthine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27808-207-01 | 27808020701 | 30 TABLET in 1 BOTTLE (27808-207-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d3b18653-9487-4a78-82c0-80ee024b8ef6NADAC price for package 27808020701
GET /v1/drugs/nadac/27808020701
Use it
Look up 27808-207 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27808-207 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27808-207. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.